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1. Introduction 
The state of ionization of the active site sulfhydryl 
group of papain at the pH-optimum of activity (pH 
Q 6.5) remains acontroversial issue. The proximity 
of an imidazole side chain to the sulkydryl, estab- 
lished by chemical means [1 ] and from X-ray mea- 
surements 121, suggests he potential for a tauto- 
merization equilibrium involving these two functions 
at this pH: 
(1) (W 
(1) 
Polgar was the first to argue for the predominance 
of If in the active site based on the mercaptide ion- 
like ultraviolet difference absorption spectrum of 
papain versus carboxymethyl- and carboxamido- 
methylpapain near neutral pH 131. Lewis et al. con- 
cluded that II is the predominant tautomer (* 90%) 
based on one interpretation of the results of their 
titrimetric procedure [4]. On the other hand, all of 
the observations reported so far regarding the state of 
the tautomerization equilibrium are best viewed as 
being in a tentative stage of interpretation (discussion 
in [.5]). 
An alternative approach to this problem is reported 
here which utilizes the difference between the isotopic 
Abbreviation: L, hydrogen ion or deuterium ion 
fractionation factor of the S-H bond (# ” 0.4 [6,7] ) 
and the N-H bond (@ = 0.97 [S]). In principle, the 
tautomerization equilibrium shown in eq. (1) shouId 
be subject o an inverse solvent deuterium isotope 
effect in which II is more stable relative to I in Da0 
compared to Hz0 (K(HaO)/K(D,O) = &H/&II = 
0.4). This principle has been successfully tested on 
the tautomerization equilibria of cysteine and 
@-mercaptoethylamine from spectrophotometric 
titrations. To the extent that these simple thioiamines 
model the spectral properties of the tautomeric spe- 
cies envisioned in the active site of papain, the 
tautom~rization equilibrium constant for papain is 
estimated (K(Hz0)=2) from a comparison of the 
effect of solvent Da0 on the mercaptide ion spectra 
of the thiolamines and the mercaptide ion-like differ- 
ence absorption spectrum of papain. 
2. Materials and methods 
Papain (Worthington) was prepared by the method 
in [9]. L-Cysteine hydrochloride monohydrate 
(Sigma) was used without further purification. 
~-Mercaptoethylamine hydrochloride (Evans Chem.) 
was twice recrystallized from warm 1 -propanol. 
Deuterium oxide, 99.8% (Bio-Rad), was distilled once 
under nitrogen. The sulkydryl content of solutions 
of thiolamines was determined by an assay using 
4-pyridine disulfide. 
Absorption spectra of cysteine and fl-mercapto- 
ethylamine were determined as a function of pL on a 
Cary 219 Scanning Spectrophotometer. Difference 
spectra of papain versus its alkylated derivatives were 
taken on a Gilford 2400-2 spectrophotometer. Active 
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site concentrations in stock solutions of activated 
papain were determined with Ellman’s reagent. For 
DzO solutions, pD values were calculated as the pH 
meter reading plus 0.4. 
3. Results and discussion 
The general ionization scheme that accounts for 
the pH-dependent ionizations of small molecular 
weight thiolamines contains a tautomerization equi- 
librium formally analogous to that envisioned in the 
active site of papain, K3*: 
2 
SH 
In this regard, cysteine and /3-mercaptoethylamine 
model two potential states of the tautomerization 
equilibrium in the active site in that for cysteine both 
2_ and 3 coexist in significant concentrations (Ka2 = 
(D] / B] )-2) while for /I-mercaptoethylamine 2 sub- 
stantially predominates over 3,. These distributions 
were first calculated [lo] from the variation of the 
mercaptide ion absorption spectrum of these thiola- 
mines with pH on the assumption that the intrinsic 
extinction coefficient (E) of the mercaptide ion of 2 
is equal to that of 3 at their respective wavelengths 
of maximum absorbancy (A,,) [lo]. In support of 
this approach, very similar values of KS2 have been 
determined for cysteine from (a) the pH-dependence of 
the Raman spectrum [ 1 l] and(b) a recent application 
of the Wegscheidler Principle using S-methylcysteine 
to estimate K13 [ 121. 
In preparation for experiments on the enzyme, 
both cysteine andfl-mercaptoethylamine were titrated 
in Hz0 and DzO by the spectrophotometric proce- 
dure [lo] to determine (a) the effect of DzO on the 
intrinsic spectral properties of the mercaptide ion 
containing forms 2 and 3 and (b) how a predicted 
inverse equilibrium solvent deuterium isotope effect 
on K, would be reflected in the pL-dependent 
absorption spectra of these compounds. Figure 1 
shows sample absorption spectra of cysteine at two 
different pLvalues in Hz0 and DzO. As demonstrated 
PL 
Fig.1. Ultraviolet absorption spectra of cysteine in 0.084 M 
NaOH (100% H,O) (A) and 0.084 M NaOD (99% D,O) (B); 
in wide range phosphate-borate-acetate buffer (16 mM in 
each buffer component), ionic strength = 0.084 M, at 
pH 10.25 (100% H,O) (C) and pD 10.25 (99% D,O) (D); 
and in 0.084 M HCl (100% H,O) (E) and 0.084 M DC1 
(99% D,O) (E). 
[lo] increasing pH produces both an increase in 
h max as well as an increase in the absorption at X,,, 
in H,O; this also holds for D,O solvent. There are 
two effects of D20 on the spectra. At high pL (A,B), 
where form 4 is the exclusive species, Dz,O produces a 
2-2.5 nm blue shift in the spectrum due to a medium 
effect, although the E at h,, remains unchanged. At 
pL 10.25 (C,D), where cysteine exists as 32% 3 and 
68% 2 plus 3 (based on the analysis in Hz0 [IO] ), 
DzO produces both a 2-2.5 nm blue shift in the spec- 
trum, comparing h,, (H,O) with X,,, (DzO), as 
well as an increase in the observed extinction coeffi- 
cient at h,, . This increase is attributed to an inverse 
equilibrium isotope effect on K3* as argued below. 
Figure 2 summarizes the variation of obs. e at 
h max, as well as the variation of A,,, taken from 
absorption spectra of cysteine as a function of pL in 
Hz0 and D*O. The term [RS-] / [RS-] max was cal- 
culated as described in the figure and normalizes 
obs. E against 1 .O. As first argued [lo], the first limb 
of the double sigmoidal curve is due to the conversion 
of 1 to 2 and its non-absorbing tautomer 3 while the 
second limb reflects the conversion of 2 and 3 to 4. 
The conversion of 2 to 4 in either solvent is also 
reflected in the increasing X,,, as pL increases. The 
h max for both 2 and 3 are subject to 2-2.5 nm blue 
shifts in DzO. In contrast to cysteine, P-mercapto- 
ethylamine exhibits nearly a single sigmoidal pL 
dependence due to the conversion of 1. to 2 and 3, 
fig.3. A second limb is only marginally detectable 
314 
Volume 110, number 2 FEBS LETTERS 
Fig.2. Spectrophotometric titration of cysteine in H,O and 
D,O in wide-range phosphate-borate-acetate buffers, 
16 mM in each buffer component and ionic strength 
adjusted to 0.084 M using NaCl; [EDTA] = 0.5 mM; 25°C. 
Closed symbols reflect the variation of the term [ RS- ] / 
[RS-I max as a function of pL calculated from the equation 
[RS-l/IRS-Imax = [(eRS_) - (cRSH)j /[(eRS-)max- 
(ERSH)max. The numerator is equal to the E of cysteine 
at A max at a given pL minus the E of cysteine in 0.1 N HCl 
(in H,O) or 0.1 N DC1 (in D,O) at the same pL and the 
same wavelength. The denominator is equal the extinction 
coefficient of cysteine in 0.1 N NaOH (in H,O) or 0.1 N 
NaOD (in D,O) at hmax --E of cysteine in 0.1 N HCl (in 
H,O) or 0.1 N DCl (in D,O) at the same wavelength. Open 
symbols reflect variation in wave-length of maximum 
absorbance (A,,,) as a function of pL. 
apparently because the equilibrium concentration of 
2, far predominates over the non-absorbing tautomer, 
3, However, the conversion of 2 and 3 to 4_ above 
pL 10 is reflected in the increasing X,,, values. As 
for cysteine, the absorbance spectrum of 2 (pL <lo) 
for /I-mercaptoethylamine is subject to a 2-2.5 nm 
blue shift in DzO. Form 4 is also subject to approxi- 
mately the same blue shift based on the X,, values 
for /I-mercaptoethylamine in 0.1 N NaOH (in H20) 
and 0.1 N NaOD (in DzO) which are 236-237 nm 
and 234-235 nm, respectively. 
The titration curves shown in fig.2 and 3 could be 
adequately fitted by eq. (2) derived on the assump- 
tion that the intrinsic extinction coefficients of 2 and 
4 are identical at their respective X,, values in each 
of the two solvents: 
@S-l - = KtzlKu + Kw P-+1 
W-1 max [L’l /Km + K,z/Kn + KM/ [L+l + 1 
(2) 
m 
5 
x 
W 
lIIiL-l 
I 230 240 250 
February 1980 
X,nm 
Fig.3. Spectrophotometric titration of p-mercaptoethylamine 
under the same conditions and using the same symbolism as 
in tIg.1. 
The computer best fit values of the microscopic ion- 
ization constants are shown in table 1. The value of 
the tautomerization equilibrium constant for cysteine 
in Hz0 using the most accurate microscopic ioniza- 
tion constants (KS2 = K12/K13 = 2.1) corresponds to 
that in [lo] within experimental error. In our hands, 
the microscopic ionization constants KM and KM 
were subject to large experimental error since their 
values depend on measuring small AEI over a large 
background absorbance above pL 9.5, fig.2. The fact 
that the calculated solvent deuterium isotope effect 
on the tautomerization constant of cysteine (KS2 
(H,O)/K, (DaO) = 0.41) is in good agreement with 
theory (Ka2 (HsO)/Kaa (DzO) = @JSH/@NH N 0.4) 
clearly supports the assumption on which eq. (2) 
was derived. An additional observation in support of 
nearly identical intrinsic E of 2 and 3 at X,,, is that 
obs. E at h,, for /I-mercaptoethylamine are nearly 
constant (25%) over pL 10.5-12.0 in both solvents, 
while the conversion of 2 to 4 is indicated from the 
increasing X,,, values. The isotope effects on 
sulfhydryl group ionizations (ApK,) for cysteine and 
/3-mercaptoethylamine, independent of the form in 
which they occur, are 0.3-0.4 while that for the 
315 
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Table 1 
Solvent deuterium isotope effects on the microscopic ionization constants for cysteine 
and p-mercaptoethylamine from spectrophotometric titrationsa 
Compound Solvent Ionization constants 
PK,, PK,, PK,, 
Cysteine D,O 
Cysteine H,O 
APKa 
p-Mercapto- 
ethylamine D,O 
P-Mercapto- 
ethylamine H,O 
APKa 
8.93 ?: 0.05 9.63 + 0.07 11.55 * 0.03 10.85 r 0.03 
8.56 f 0.05 8.89 f 0.07 10.99 * 0.15 10.56 + 0.15 
0.37 f 0.1 0.74 f 0.15 0.56 + 0.45 0.29 * 0.45 
8.74 f 0.05 
3.36 r 0.05 
0.38 f 0.1 
a Ionization constants obtained from the computer best fit of eq. (2) to the data of 
fig.2,3 
b Calculated from the best fit values to eq. (2) and the equality K,, /K,, = K,, /K,, 
amino group ionizations are 0.5-0.7. These values 
compare reasonably well with solvent isotope effects 
on sulfhydryl group and amino group ionizations for 
compounds in which these groups do not occur in the 
same molecule [ 131. 
Based on the results of the model studies, the 
magnitude of the tautomerization equilibrium con- 
stant of papain, eq. (1) was estimated from the 
relative effect of DzO and HZ0 on the M spectrum 
of papain versus carboxymethyl- or carboxamido- 
methyl-papain in the 240-270 nm region (experi- 
mentally accessible because of the relatively low 
Fig.4. Ultraviolet difference spectra of papain (0.016 mM) 
versus carboxamido methylpapain (0.016 mM) at high pL in 
100% H,O (0, pH 10.0) and 98% D,O (0, pD 10.26) and 
papain (0.03 mM) versus carboxymethylpapain (0.03 mM) 
near neutral pL in 100% H,O (0, pH 6.5) and 98% D,O (o, 
PD 6.5). The difference spectra were generated by the 
alkylation procedure detailed in [ 31. The carboxamidomethyl 
derivative of papain was chosen for the high pL spectra 
because chloroacetamide reacts with papain at a conveniently 
fast rate, while chloroacetate reacts very slowly [14,15]. 
Conversely, the carboxymethyl derivative was chosen for the 
neutral pL spectra because chloroacetate reacts rapidly with 
the enzyme, while chloroacetamide reacts only slowly 
[14,15]. The AA is independent of whether chloroacetate or 
chloroacetamide isused in the alkylation procedure [ 31. 
Theoretical spectra are shown due to: (a) a 2.5 nm blue shift 
of the observed spectra in H,O near neutral pL (X); (b) a 
2.5 nm blue shift of the observed spectra in H,O at neutral 
pL plus a 25% increase in the extinction coefficients at all 
wavelengths (---); (c) a 5 nm blue shift of the high pL 
spectrum in H,O (A-A). 
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background absorbance of the protein) attributed to 
the long wavelength region of the absorption spec- 
trum of an active site mercaptide ion [3]. The obser- 
vations (fig.4) and arguments which lead to the con- 
clusion of K(H20) = 2 are as follows: 
(1) The hypothesis that the M at high pL is due to 
a mercaptide ion, is supported by two observa- 
tions: (i) At high pL where the active site sulf- 
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hydryl is completely ionized, the difference spec- 
trum is subject o a 2-2.5 nm blue shift in D,O, 
an effect modeled by both cysteine and &mer- 
captoethylamine athigh pL, fig.1 (A,B), 
2,3; (ii) The wavelength-dependent AE for the 
enzyme in Ha0 and D,O correspond to 5 10% of 
the E of cysteine at high pL in Hz0 and DzO, 
fig.1. 
(2) >95% of the M at pL 6.5 must be due to the 
tautomeric forms of papain, based on the demon- 
stration that the appearance of the M due to II 
is controlled by an app. pK, = 4 while the con- 
version of II and its non-absorbing tautomer III 
to the completely ionized form of papain at high 
pH is controlled by an app. pKa =8.S 131. 
(3) The effect of Da0 on the difference spectrum of 
papain at pL 6.5 can be attributed to the com- 
bination of a 2.5 nm blue shift in the absorption 
spectrum due to II (X) plus a 25% increase in the 
app. E of the blue-shifted spectrum at all wave- 
lengths, resulting in a theoretical spectrum in 
DsO (---) in close agreement with the observed 
spectrum in DzO. This is qualitativeIy analogous 
to the effect of DzO on the spectrum of cysteine 
at pL 10.25 in the 240-260 nm region where the 
tautomeric forms 2 and 3_ coexist, fig.IC,D. 
(4) Assuming that the intrinsic extinction coefficients 
of II in Ha0 and DzO are identical at pL 6.5, 
after correcting for the blue shift, the 25% 
increase in app. E used to account for the spec- 
trum in Da0 is interpreted as a 25% increase in II 
at the expense of the non-absorbing tautomer III. 
The assumption on which this conclusion is 
based is as good as the ability of cysteine to 
model the intrinsic spectral properties of the 
tautomeric forms of papain: The solvent isotope 
on KS2 for cysteine was demonstrated to be in 
good agreement with theory based on an analysis 
in which the intrinsic E at X,, of _2. in Ha0 and 
Da0 were assumed equal to the intrinsic E 3 at 
x max in Hz0 and DaO, respectively. In so far as 
the intrinsic E of 3 at h,, are themselves qual 
in the two solvents (fig.1) the intrinsic extinc- 
tion coefficients of 2 at h,, in the two solvents 
are also equal. 
(5) The tautomerization equilibrium constant for the 
enzyme in Hz0 (K(H,O) = [II] /[I] ) can be cal- 
culated from eq. (3) in which R = [IIID,*/ 
fIIJH,O = 1.25: 
(3) 
Given the reported isotopic fractionation factors 
of the N-H bond (4~~ = 0.97 [S]) and the S-H 
bond (#SN = 0.40 [6,7] ), K(Ha0) = 2, corre- 
sponding to ?I 66% II in the active site. 
(6) A similar value for the % II in the active site can 
be deducted independent of solvent isotope 
effects by assuming that the imidazolium ion of 
II causes a5 nm blue shift in the absorbance 
spectrum of the neighboring mercaptide ion, in 
analogy with the 5 nm blue shift in Hz0 of the 
mercaptide ion spectrum of form 2 of cysteine 
due to the neighboring ammonium ion, fig.2. A 
5 nm blue shift of the observed spectrum at high 
pL for the enzyme in HaO, fig.3, gives a spec- 
trum that would be anticipated if the enzyme 
were 100% 2. near neutral pL (u), The dif- 
ference between this spectrum and that observed 
near neutral pLin Ha0 (0-0) could be accounted 
for by the presence of 40-50% non-absorbing 
III in the active site. 
In summary, there are two observations reported 
here that may have an important bearing on the state 
of the tautomerization equ~ibrium in the active site 
of papain. 
1. Solvent D,O has been shown to be a predictable 
perturbant of tautomerizatjon equilibria invol~ng 
sulthydryl groups, based on the results of the 
model studies. 
2. There is a striking similarity between the effect of 
Da0 on the spectral properties of small molecular 
weight hiolamines and the mercaptide ion-like 
difference absorption spectrum of papain. 
This has allowed an estimate of the tautomerization 
equilibrium constant for the enzyme based on the 
assumption that the thiolamines are good models of 
the intrinsic spectral properties of the tautomeric 
forms of the enzyme. On the other hand, the possi- 
bility that the spectral properties of papain are unique 
only to the enzyme and therefore a direct comparison 
with simple thiolamines inappropriate must still be 
considered. In this regard, a substantially arger 
tautomerization constant has been calculated for 
papain (K(H,O) = 8-12) based on very different but 
no less arguable assumptions [4]. In any event, the 
particular experimental pproach reported here must 
be given utmost consideration before any final deci- 
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sions are made with respect to the equilibrium dis 
tribution of tautomeric forms in the active site of 
papain. 
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